Overview
Portfolio
More
Sprucecp
San Francisco, United States
Investors in innovative AG, Industrial, and Food & Nutrition Life Sciences companies shaping tomorrow.
Portfolio
14+
Employees
<3
Founded
2013
AUM
≈ $146.4M
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Sprucecp
Investors in innovative AG, Industrial, and Food & Nutrition Life Sciences companies shaping tomorrow.
Portfolio
14+
Employees
<3
Founded
2013
AUM
≈ $146.4M
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Showing 7 of 7 matched portfolio companies
The startup operates a biotechnology platform that utilizes gene editing techniques to enhance the protein density of soybean and other crops. This approach addresses the increasing global demand for protein-rich foods by providing more nutritionally dense and cost-effective plant-based food sources.
GreenLight Biosciences produces RNA‑interference (RNAi) biopesticides that silence target genes in insects, fungi, and weeds, delivering species‑level specificity with rapid environmental degradation and no residue on crops. Their scalable manufacturing platform creates commercial‑grade foliar sprays compatible with standard farm equipment, offering growers a residue‑free, EPA‑approved alternative to conventional chemicals.
This company develops microbiome-based therapeutics to improve infant gut health and prevent conditions like necrotizing enterocolitis. Their drugs, currently undergoing clinical trials, aim to support healthy immune system function in infants, particularly preterm babies.
Funding: $55.0M
Rough estimate of the amount of funding raised
Funding: $55.0M
Rough estimate of the amount of funding raised
Inscripta provides the MAD7™ genome‑editing platform, an IP‑free CRISPR‑derived nuclease designed for high‑efficiency editing in microbial and cell‑based production strains. Through an open licensing program and compatible software tools, it enables industrial biotech and synthetic biology companies to rapidly develop and scale sustainable bio‑alternatives without royalty fees.
Funding: $461.4M
Rough estimate of the amount of funding raised
Funding: $461.4M
Rough estimate of the amount of funding raised
LanzaTech utilizes gas fermentation technology to convert industrial waste carbon emissions into sustainable fuels, chemicals, and materials. This process directly addresses the challenge of carbon pollution by transforming harmful emissions into valuable resources, contributing to a circular economy.
Funding: $200.0M
Rough estimate of the amount of funding raised
Funding: $200.0M
Rough estimate of the amount of funding raised
Pivot Bio is an agricultural technology company that utilizes microbial solutions to convert atmospheric nitrogen into a form that is readily accessible to plants. This process enhances soil fertility and reduces the reliance on synthetic fertilizers, addressing nutrient deficiencies in crops.
Funding: $430.0M
Rough estimate of the amount of funding raised
Funding: $430.0M
Rough estimate of the amount of funding raised
This company develops insect pheromones that offer a non-toxic method of crop protection. Their pheromone-based solutions provide farmers with a sustainable and effective alternative to traditional pesticides for safeguarding food supplies.
Funding: $76.5M
Rough estimate of the amount of funding raised
Funding: $76.5M
Rough estimate of the amount of funding raised
Showing 7 of 7 unmatched portfolio companies